Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with

Takeshi Hatanaka1, Satoru Kakizaki2,3, Takuya Kaburagi1

  • 1Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Japan.

Insights

This study reports the first identification of Hepatitis C Virus (HCV) subtype 1g in Japan. The patient, infected with a drug-resistant strain, was successfully treated with glecaprevir/pibrentasvir combination therapy.

Area of Science:

  • Virology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic Hepatitis C (HCV) is a significant global health concern.
  • HCV exhibits remarkable genetic diversity, with numerous subtypes and quasispecies.
  • Understanding HCV subtype distribution is crucial for epidemiological tracking and treatment strategies.

Observation:

  • A 66-year-old male patient with chronic Hepatitis C (HCV) infection was identified.
  • The patient had a history of plasma exchange in Egypt 30 years prior for falciparum malaria.
  • Analysis revealed the presence of HCV subtype 1g, a novel finding in Japan.

Findings:

  • Phylogenetic analysis confirmed the patient's HCV infection as subtype 1g.
  • The identified HCV strain possessed naturally occurring resistance-associated substitutions in the NS3 and NS5A regions.
  • Successful treatment was achieved using a combination therapy of glecaprevir/pibrentasvir.

Implications:

  • This case marks the first documented instance of HCV subtype 1g in Japan.
  • The findings highlight the importance of molecular diagnostics for identifying rare HCV subtypes.
  • Effective treatment of drug-resistant HCV subtypes with direct-acting antivirals is feasible.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
140
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
319
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
2.9K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
179
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
19